ArticleThe Journal of pathology2022

Functional genomics screening identifies aspartyl-tRNA synthetase as a novel prognostic marker and a therapeutic target for gastric cancers.

Bin Liu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.